Skip to content

CIK 0000318154

AMGN AMGEN INC

Insider trading from SEC Form 4. Last filing Dec 6, 2024.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company

Signals

Open-market buys and sells at AMGEN INC, scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Congressional trades

35 trades in AMGN disclosed by members of Congress under the STOCK Act, the newest 20 shown. All congressional trades.

MemberTypeAssetAmountTradedFiled
David J. Taylor
House · R-OH
PurchaseAMGN
Amgen Inc. - Common Stock
$1,001 to $15kSep 22, 2026
9 days after the trade
David J. Taylor
House · R-OH
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kAug 26, 2026
10 days after the trade
David J. Taylor
House · R-OH
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kAug 26, 2026
10 days after the trade
Sheldon Whitehouse
Senate · D-RI
Partial saleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kAug 12, 2026
21 days after the trade
Tommy Tuberville
Senate · R-AL
SaleAMGN
Amgen Inc
$15k to $50kApr 15, 2025
477 days after the trade
Alan Armstrong
Senate · R-OK
SaleAMGN
Amgen Inc. - Common Stock
$15k to $50kMar 27, 2026
116 days after the trade
David J. Taylor
House · R-OH
PurchaseAMGN
Amgen Inc. - Common Stock
$1,001 to $15kJun 5, 2026
7 days after the trade
Maria Elvira Salazar
House · R-FL
SaleAMGN
Amgen Inc. - Common Stock
$15k to $50kApr 17, 2026
21 days after the trade
Maria Elvira Salazar
House · R-FL
PurchaseAMGN
Amgen Inc. - Common Stock
$15k to $50kMar 24, 2026
28 days after the trade
David J. Taylor
House · R-OH
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kFeb 26, 2026
8 days after the trade
David J. Taylor
House · R-OH
PurchaseAMGN
Amgen Inc. - Common Stock
$1,001 to $15kJan 16, 2026
17 days after the trade
David J. Taylor
House · R-OH
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kJan 29, 2026
4 days after the trade
Julia Letlow
House · R-LA
PurchaseAMGN
Amgen Inc. - Common Stock
$1,001 to $15kOct 23, 2024
447 days after the trade
Julia Letlow
House · R-LA
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kNov 19, 2024
420 days after the trade
David J. Taylor
House · R-OH
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kDec 3, 2025
2 days after the trade
David J. Taylor
House · R-OH
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kDec 3, 2025
2 days after the trade
Marjorie Taylor Greene
House · R-GA
PurchaseAMGN
Amgen Inc. - Common Stock
$1,001 to $15kOct 24, 2025
4 days after the trade
Lisa C. McClain
House · R-MI
SaleAMGN
Amgen Inc. - Common Stock
$1,001 to $15kSep 25, 2025
27 days after the trade
Sheldon Whitehouse
Senate · D-RI
SaleAMGN
Amgen Inc
$1,001 to $15kSep 4, 2025
29 days after the trade
Marjorie Taylor Greene
House · R-GA
PurchaseAMGN
Amgen Inc. - Common Stock
$1,001 to $15kSep 11, 2025
16 days after the trade

Transactions

The last 9 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Dec 5, 2024Graham Jonathan P
EVP & Gen. Counsel & Secy.
GGift
Common Stock
-6,430$0.00$028,903Dec 6, 2024
Dec 2, 2024Bradway Robert A
Chairman, CEO and President
GGift
Common Stock
-96,000$0.00$0573,855Dec 3, 2024
Dec 2, 2024Bradway Robert A
Chairman, CEO and President
GGift
Common Stockindirect: By Spousal GRAT
+90,000$0.00$090,000Dec 3, 2024
Dec 2, 2024Bradway Robert A
Chairman, CEO and President
GGift
Common Stock
-90,000$0.00$0393,855Dec 3, 2024
Nov 5, 2024Busch Matthew C.
VP, Finance & CAO
FTax withholding
Common Stock
-189$316.91$60k4,770Nov 6, 2024
Nov 5, 2024Khosla Rachna
SVP, Business Development
FTax withholding
Common Stock
-212$316.91$67k8,383Nov 6, 2024
Nov 4, 2024Drake Michael V
director
AGrant or award
Common Stock
+221$0.00$03,552Nov 6, 2024
Nov 4, 2024HOLLEY CHARLES M
director
AGrant or award
Common Stock
+268$0.00$010,114Nov 6, 2024
Nov 4, 2024ISHRAK OMAR
director
AGrant or award
Common Stock
+221$0.00$05,081Nov 6, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.